Gujarat Kidney And Super Speciality Limited vs Zydus Lifesciences Limited
A side-by-side comparison of Gujarat Kidney And Super Speciality Limited (GKSL) and Zydus Lifesciences Limited (ZYDUSLIFE) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, Zydus Lifesciences Limited leads GKSL vs ZYDUSLIFE on 9 of 14 metrics (2 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation04
- Profitability22
- Growth· not comparable—
- Size & financial health13
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
ZYDUSLIFE takes 4/4How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
EvenHow efficiently each company turns capital and sales into profit. Higher is better.
Growth
Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
ZYDUSLIFE takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company has delivered good profit growth of 191.4% CAGR over last 5 years", "Company has a good return on equity (ROE) track record: 3 Years ROE 34.1%", "Company is almost debt free.", "Company has delivered good sales growth of 136.9% CAGR over last 5 years"]
- − ["Stock is trading at 5.85 times its book value", "Though the company is reporting repeated profits, it is not paying out dividend"]
- + ["Company has delivered good profit growth of 18.6% CAGR over last 5 years", "Company has a good return on equity (ROE) track record: 3 Years ROE 20.9%"]
- − []
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.